维他奶(00345.HK)强烈否认沽空机构报告指控 属不准确及具误导性
维他奶(00345.HK)公布,董事会注意到,沽空机构Valiant Varriors发表之市场研究报告载有关於集团之若干指控。董事会强烈否认该报告所载之指控,并认为该等指控并不准确及具误导性。
沽空机构Valiant Varriors发表看淡维他奶报告,声称其夸大盈利及资本支出,给出目标价10元。报告声言,公司管理层在众目睽睽下隐瞒诸多事实,为了在财务报表上体现高毛利率,而严重夸大於中国及澳大利亚的利润及资本支出,同时少报成本上升对公司的影响,指其在财务报表中的数字,与其在中国及澳大利亚提交的官方数据严重不符。
维他奶股价最新报29.05元,升4.9%,成交增至1,600万股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.